NewsDialy
Protillion Biosciences has hired Robert Hollingsworth as its chief scientific officer, according to the STAT+ executive-tracking column "Up and Down the Ladder." Hollingsworth previously held the same title at Shoreline Therapeutics and, before that, served at Pfizer as vice president and chief scientific officer of cancer vaccines and immunotherapeutics.
A Role He Has Occupied Before Chief scientific officer — the executive responsible for directing a company's research agenda and deciding which programs move forward — is typically the most senior purely scientific position inside a life sciences firm.
It is distinct from the chief medical officer, who oversees clinical development, and from the chief executive, who runs the business. The CSO sets the scientific vision and manages how research resources are allocated.
Hollingsworth is not stepping into this authority for the first time.
Keep reading